nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PLA2G4A—asthma	0.345	0.827	CbGaD
Niflumic Acid—PLA2G4A—Fluticasone Propionate—asthma	0.144	0.303	CbGbCtD
Niflumic Acid—PLA2G1B—Betamethasone—asthma	0.11	0.233	CbGbCtD
Niflumic Acid—PTGS2—asthma	0.072	0.173	CbGaD
Niflumic Acid—PLA2G1B—Dexamethasone—asthma	0.0643	0.135	CbGbCtD
Niflumic Acid—UGT1A9—Zileuton—asthma	0.0608	0.128	CbGbCtD
Niflumic Acid—PTGS1—Zileuton—asthma	0.0252	0.0532	CbGbCtD
Niflumic Acid—PTGS1—Zafirlukast—asthma	0.0222	0.0468	CbGbCtD
Niflumic Acid—PTGS1—Montelukast—asthma	0.0163	0.0343	CbGbCtD
Niflumic Acid—PTGS2—Triamcinolone—asthma	0.0133	0.0281	CbGbCtD
Niflumic Acid—PTGS2—Betamethasone—asthma	0.0115	0.0241	CbGbCtD
Niflumic Acid—PTGS2—Dexamethasone—asthma	0.00666	0.014	CbGbCtD
Niflumic Acid—PLA2G1B—exocrine gland—asthma	0.00401	0.111	CbGeAlD
Niflumic Acid—PLA2G1B—respiratory system—asthma	0.00209	0.0577	CbGeAlD
Niflumic Acid—PLA2G1B—epithelium—asthma	0.00174	0.0482	CbGeAlD
Niflumic Acid—PLA2G1B—cardiovascular system—asthma	0.0016	0.0442	CbGeAlD
Niflumic Acid—SLC16A7—adrenal cortex—asthma	0.00147	0.0408	CbGeAlD
Niflumic Acid—SLC16A7—bronchus—asthma	0.00145	0.04	CbGeAlD
Niflumic Acid—SLC16A7—cardiovascular system—asthma	0.00135	0.0372	CbGeAlD
Niflumic Acid—SLC16A7—trachea—asthma	0.0013	0.0359	CbGeAlD
Niflumic Acid—PLA2G4A—respiratory system—asthma	0.00127	0.0351	CbGeAlD
Niflumic Acid—PLA2G1B—adrenal gland—asthma	0.00126	0.0349	CbGeAlD
Niflumic Acid—PLA2G1B—lung—asthma	0.00111	0.0306	CbGeAlD
Niflumic Acid—PLA2G4A—adrenal cortex—asthma	0.00107	0.0295	CbGeAlD
Niflumic Acid—SLC16A7—adrenal gland—asthma	0.00106	0.0294	CbGeAlD
Niflumic Acid—PLA2G4A—bronchus—asthma	0.00105	0.0289	CbGeAlD
Niflumic Acid—PLA2G4A—smooth muscle tissue—asthma	0.00102	0.0283	CbGeAlD
Niflumic Acid—PLA2G4A—cardiovascular system—asthma	0.000973	0.0269	CbGeAlD
Niflumic Acid—PLA2G4A—trachea—asthma	0.000939	0.026	CbGeAlD
Niflumic Acid—SLC16A1—epithelium—asthma	0.000934	0.0258	CbGeAlD
Niflumic Acid—SLC16A7—lung—asthma	0.000933	0.0258	CbGeAlD
Niflumic Acid—SLC16A1—cardiovascular system—asthma	0.000856	0.0237	CbGeAlD
Niflumic Acid—PLA2G4A—adrenal gland—asthma	0.000769	0.0213	CbGeAlD
Niflumic Acid—SLC16A1—adrenal gland—asthma	0.000677	0.0187	CbGeAlD
Niflumic Acid—PLA2G4A—lung—asthma	0.000674	0.0186	CbGeAlD
Niflumic Acid—SLC16A1—lung—asthma	0.000594	0.0164	CbGeAlD
Niflumic Acid—PTGS1—respiratory system—asthma	0.000502	0.0139	CbGeAlD
Niflumic Acid—PTGS2—respiratory system—asthma	0.000479	0.0133	CbGeAlD
Niflumic Acid—PLA2G4A—Glyburide—Zafirlukast—asthma	0.000445	0.138	CbGdCrCtD
Niflumic Acid—PTGS1—epithelium—asthma	0.000419	0.0116	CbGeAlD
Niflumic Acid—PTGS1—smooth muscle tissue—asthma	0.000404	0.0112	CbGeAlD
Niflumic Acid—PTGS2—adrenal cortex—asthma	0.000402	0.0111	CbGeAlD
Niflumic Acid—PTGS2—epithelium—asthma	0.000401	0.0111	CbGeAlD
Niflumic Acid—PTGS2—bronchus—asthma	0.000395	0.0109	CbGeAlD
Niflumic Acid—PTGS2—smooth muscle tissue—asthma	0.000386	0.0107	CbGeAlD
Niflumic Acid—PTGS1—cardiovascular system—asthma	0.000384	0.0106	CbGeAlD
Niflumic Acid—Floctafenine—PTGS2—asthma	0.000373	0.719	CrCbGaD
Niflumic Acid—PTGS1—trachea—asthma	0.000371	0.0103	CbGeAlD
Niflumic Acid—PTGS2—cardiovascular system—asthma	0.000367	0.0102	CbGeAlD
Niflumic Acid—PTGS2—trachea—asthma	0.000354	0.0098	CbGeAlD
Niflumic Acid—PTGS1—adrenal gland—asthma	0.000304	0.0084	CbGeAlD
Niflumic Acid—PTGS2—adrenal gland—asthma	0.00029	0.00803	CbGeAlD
Niflumic Acid—PTGS1—lung—asthma	0.000266	0.00737	CbGeAlD
Niflumic Acid—PTGS2—lung—asthma	0.000255	0.00704	CbGeAlD
Niflumic Acid—PTGS2—Fluocinonide—Ciclesonide—asthma	0.000206	0.0638	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Fluticasone furoate—asthma	0.000202	0.0625	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Fluticasone Propionate—asthma	0.000188	0.0583	CbGdCrCtD
Niflumic Acid—Mefenamic acid—PTGS2—asthma	0.000146	0.281	CrCbGaD
Niflumic Acid—PTGS2—Fluocinonide—Beclomethasone—asthma	0.000138	0.0429	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Budesonide—asthma	0.000132	0.0411	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Flunisolide—asthma	0.000131	0.0405	CbGdCrCtD
Niflumic Acid—PLA2G4A—Pindolol—Isoprenaline—asthma	0.000123	0.0381	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Fluticasone furoate—asthma	0.000122	0.0377	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Mometasone—asthma	0.000107	0.0332	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Beclomethasone—asthma	8.34e-05	0.0259	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Flunisolide—asthma	7.89e-05	0.0245	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Mometasone—asthma	6.46e-05	0.02	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Methylprednisolone—asthma	6.4e-05	0.0198	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Fluticasone furoate—asthma	6.36e-05	0.0197	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Fluticasone furoate—asthma	6.36e-05	0.0197	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Betamethasone—asthma	6.3e-05	0.0195	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Dexamethasone—asthma	6.3e-05	0.0195	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Triamcinolone—asthma	6.15e-05	0.0191	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Fluticasone Propionate—asthma	5.93e-05	0.0184	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Fluticasone Propionate—asthma	5.93e-05	0.0184	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Beclomethasone—asthma	4.36e-05	0.0135	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Beclomethasone—asthma	4.36e-05	0.0135	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Budesonide—asthma	4.18e-05	0.013	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Budesonide—asthma	4.18e-05	0.013	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Flunisolide—asthma	4.12e-05	0.0128	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Flunisolide—asthma	4.12e-05	0.0128	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Methylprednisolone—asthma	3.86e-05	0.012	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Dexamethasone—asthma	3.8e-05	0.0118	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Betamethasone—asthma	3.8e-05	0.0118	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Triamcinolone—asthma	3.71e-05	0.0115	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Mometasone—asthma	3.38e-05	0.0105	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Mometasone—asthma	3.38e-05	0.0105	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Hydrocortisone—asthma	2.14e-05	0.00663	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Hydrocortisone—asthma	2.14e-05	0.00663	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Methylprednisolone—asthma	2.02e-05	0.00626	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Methylprednisolone—asthma	2.02e-05	0.00626	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Betamethasone—asthma	1.99e-05	0.00616	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Dexamethasone—asthma	1.99e-05	0.00616	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Triamcinolone—asthma	1.94e-05	0.00602	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Triamcinolone—asthma	1.94e-05	0.00602	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Prednisone—asthma	1.84e-05	0.00571	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Prednisone—asthma	1.84e-05	0.00571	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Prednisolone—asthma	1.8e-05	0.00557	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Prednisolone—asthma	1.8e-05	0.00557	CbGdCrCtD
Niflumic Acid—PTGS2—Metabolism—LTA4H—asthma	1.79e-05	0.000261	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—ADCY2—asthma	1.79e-05	0.000261	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALOX5—asthma	1.79e-05	0.00026	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALDH7A1—asthma	1.79e-05	0.00026	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL3—asthma	1.78e-05	0.00026	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ALB—asthma	1.75e-05	0.000255	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALOX15—asthma	1.74e-05	0.000254	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALOX5AP—asthma	1.74e-05	0.000254	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CYSLTR1—asthma	1.74e-05	0.000253	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ARG2—asthma	1.71e-05	0.000249	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TGFB1—asthma	1.71e-05	0.000249	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CARM1—asthma	1.7e-05	0.000248	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—asthma	1.69e-05	0.000247	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—KNG1—asthma	1.68e-05	0.000245	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—DCN—asthma	1.68e-05	0.000245	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—EGFR—asthma	1.68e-05	0.000244	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VIP—asthma	1.68e-05	0.000244	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—UTS2—asthma	1.68e-05	0.000244	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—C5AR1—asthma	1.68e-05	0.000244	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CMA1—asthma	1.68e-05	0.000244	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL11—asthma	1.68e-05	0.000244	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—AGTR1—asthma	1.67e-05	0.000244	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NQO1—asthma	1.66e-05	0.000242	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CHAT—asthma	1.66e-05	0.000242	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IL2—asthma	1.64e-05	0.000239	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL10—asthma	1.63e-05	0.000238	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALDH2—asthma	1.63e-05	0.000238	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL6—asthma	1.63e-05	0.000237	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ADCY2—asthma	1.63e-05	0.000237	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCR4—asthma	1.61e-05	0.000234	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—asthma	1.6e-05	0.000233	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—ADRB2—asthma	1.59e-05	0.000231	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—SERPINE1—asthma	1.58e-05	0.00023	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—STAT6—asthma	1.58e-05	0.00023	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—ALB—asthma	1.57e-05	0.000229	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—asthma	1.57e-05	0.000229	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ARG1—asthma	1.57e-05	0.000228	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTT1—asthma	1.55e-05	0.000226	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2RB—asthma	1.55e-05	0.000225	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—POMC—asthma	1.54e-05	0.000224	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDE4D—asthma	1.53e-05	0.000223	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—RHOA—asthma	1.52e-05	0.000222	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—NOS3—asthma	1.51e-05	0.000219	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.5e-05	0.000219	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—ITPR1—asthma	1.5e-05	0.000219	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDE4B—asthma	1.49e-05	0.000218	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—C5—asthma	1.49e-05	0.000218	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TACR1—asthma	1.49e-05	0.000218	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALOX5—asthma	1.48e-05	0.000216	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—asthma	1.43e-05	0.000209	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALOX5AP—asthma	1.42e-05	0.000207	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALOX15—asthma	1.42e-05	0.000207	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALDH7A1—asthma	1.42e-05	0.000207	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—EDN1—asthma	1.42e-05	0.000206	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CARM1—asthma	1.41e-05	0.000206	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCL5—asthma	1.41e-05	0.000205	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—asthma	1.4e-05	0.000204	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ALB—asthma	1.4e-05	0.000204	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—VEGFA—asthma	1.39e-05	0.000203	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—DCN—asthma	1.39e-05	0.000203	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CSF2—asthma	1.39e-05	0.000202	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTP1—asthma	1.39e-05	0.000202	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCR3—asthma	1.37e-05	0.000199	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—HMOX1—asthma	1.37e-05	0.000199	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ITPR1—asthma	1.36e-05	0.000199	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ARG2—asthma	1.36e-05	0.000198	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALDH2—asthma	1.35e-05	0.000197	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CHAT—asthma	1.35e-05	0.000197	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CAT—asthma	1.35e-05	0.000196	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—NOS3—asthma	1.34e-05	0.000195	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NPY—asthma	1.33e-05	0.000194	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—POMC—asthma	1.3e-05	0.00019	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NQO1—asthma	1.29e-05	0.000188	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PPP2CA—asthma	1.29e-05	0.000188	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL6—asthma	1.29e-05	0.000188	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTT1—asthma	1.29e-05	0.000188	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AGTR2—asthma	1.28e-05	0.000187	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TGFB1—asthma	1.28e-05	0.000186	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IL2—asthma	1.28e-05	0.000186	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PLA2G4A—asthma	1.27e-05	0.000185	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTM1—asthma	1.27e-05	0.000185	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	1.27e-05	0.000185	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCR5—asthma	1.27e-05	0.000185	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ADCY2—asthma	1.26e-05	0.000184	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.25e-05	0.000183	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL2RA—asthma	1.25e-05	0.000182	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—C3—asthma	1.24e-05	0.00018	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EDNRB—asthma	1.23e-05	0.000179	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTGS2—asthma	1.23e-05	0.000179	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TAC1—asthma	1.22e-05	0.000177	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NPS—asthma	1.22e-05	0.000177	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALOX5—asthma	1.21e-05	0.000176	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCR3—asthma	1.19e-05	0.000174	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.19e-05	0.000174	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ALB—asthma	1.19e-05	0.000173	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PPP2CA—asthma	1.17e-05	0.000171	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	1.16e-05	0.000169	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CYBA—asthma	1.16e-05	0.000168	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CARM1—asthma	1.15e-05	0.000168	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—asthma	1.14e-05	0.000166	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—DCN—asthma	1.13e-05	0.000165	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PARP1—asthma	1.13e-05	0.000165	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL5—asthma	1.13e-05	0.000165	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALOX5AP—asthma	1.13e-05	0.000164	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALOX15—asthma	1.13e-05	0.000164	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALDH2—asthma	1.1e-05	0.000161	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—asthma	1.09e-05	0.000159	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—BDKRB2—asthma	1.09e-05	0.000159	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—asthma	1.09e-05	0.000158	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—VEGFA—asthma	1.08e-05	0.000158	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTP1—asthma	1.08e-05	0.000157	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—DCN—asthma	1.08e-05	0.000157	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CHAT—asthma	1.08e-05	0.000157	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NQO1—asthma	1.07e-05	0.000156	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTEN—asthma	1.07e-05	0.000156	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—HMOX1—asthma	1.06e-05	0.000155	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—asthma	1.06e-05	0.000155	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ITPR1—asthma	1.06e-05	0.000154	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADCY2—asthma	1.06e-05	0.000154	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL3—asthma	1.05e-05	0.000153	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTT1—asthma	1.05e-05	0.000153	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CAT—asthma	1.05e-05	0.000153	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ADCY2—asthma	1.05e-05	0.000153	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.04e-05	0.000151	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TGFB1—asthma	9.95e-06	0.000145	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—KNG1—asthma	9.94e-06	0.000145	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—POMC—asthma	9.91e-06	0.000144	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTM1—asthma	9.9e-06	0.000144	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AGTR1—asthma	9.88e-06	0.000144	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCL2—asthma	9.69e-06	0.000141	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—asthma	9.68e-06	0.000141	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6R—asthma	9.66e-06	0.000141	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL10—asthma	9.65e-06	0.000141	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALOX5—asthma	9.58e-06	0.00014	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NTRK1—asthma	9.47e-06	0.000138	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADRB2—asthma	9.37e-06	0.000136	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CARM1—asthma	9.14e-06	0.000133	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PPP2CA—asthma	9.12e-06	0.000133	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—asthma	9.06e-06	0.000132	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—DCN—asthma	9.01e-06	0.000131	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—POMC—asthma	9e-06	0.000131	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTP1—asthma	8.93e-06	0.00013	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ITPR1—asthma	8.87e-06	0.000129	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CYBA—asthma	8.86e-06	0.000129	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—HMOX1—asthma	8.8e-06	0.000128	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ITPR1—asthma	8.79e-06	0.000128	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALDH2—asthma	8.76e-06	0.000128	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—RHOA—asthma	8.73e-06	0.000127	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NQO1—asthma	8.73e-06	0.000127	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CAT—asthma	8.69e-06	0.000127	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PARP1—asthma	8.67e-06	0.000126	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ADCY2—asthma	8.54e-06	0.000124	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—asthma	8.47e-06	0.000123	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CD86—asthma	8.44e-06	0.000123	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—asthma	8.43e-06	0.000123	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EDN1—asthma	8.38e-06	0.000122	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTT1—asthma	8.34e-06	0.000121	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL5—asthma	8.31e-06	0.000121	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PLA2G4A—asthma	8.2e-06	0.000119	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ALB—asthma	8.2e-06	0.000119	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTM1—asthma	8.2e-06	0.000119	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CSF2—asthma	8.19e-06	0.000119	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS1—asthma	8.15e-06	0.000119	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ADCY2—asthma	8.09e-06	0.000118	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SMAD3—asthma	7.97e-06	0.000116	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NOS3—asthma	7.85e-06	0.000114	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—asthma	7.68e-06	0.000112	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL8—asthma	7.66e-06	0.000112	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PPP2CA—asthma	7.62e-06	0.000111	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPP2CA—asthma	7.56e-06	0.00011	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCR5—asthma	7.49e-06	0.000109	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—asthma	7.38e-06	0.000108	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2RA—asthma	7.38e-06	0.000107	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL2—asthma	7.32e-06	0.000107	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—C3—asthma	7.32e-06	0.000107	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTP1—asthma	7.28e-06	0.000106	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—HMOX1—asthma	7.18e-06	0.000105	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS2—asthma	7.18e-06	0.000105	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ITPR1—asthma	7.16e-06	0.000104	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDGFB—asthma	7.12e-06	0.000104	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CAT—asthma	7.08e-06	0.000103	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—POMC—asthma	7e-06	0.000102	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NQO1—asthma	6.93e-06	0.000101	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LEP—asthma	6.81e-06	9.92e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ITPR1—asthma	6.79e-06	9.89e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ADCY2—asthma	6.78e-06	9.87e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PLA2G4A—asthma	6.69e-06	9.74e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTM1—asthma	6.69e-06	9.74e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CD86—asthma	6.46e-06	9.41e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FN1—asthma	6.42e-06	9.36e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALB—asthma	6.38e-06	9.29e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTEN—asthma	6.26e-06	9.12e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPP2CA—asthma	6.16e-06	8.97e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NOS3—asthma	6.1e-06	8.89e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SMAD3—asthma	6.1e-06	8.89e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—asthma	5.86e-06	8.54e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—POMC—asthma	5.85e-06	8.52e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PPP2CA—asthma	5.84e-06	8.5e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—POMC—asthma	5.8e-06	8.45e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTP1—asthma	5.78e-06	8.41e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CCR5—asthma	5.73e-06	8.35e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL2—asthma	5.73e-06	8.34e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6R—asthma	5.71e-06	8.31e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HMOX1—asthma	5.7e-06	8.3e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ITPR1—asthma	5.69e-06	8.28e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CAT—asthma	5.62e-06	8.19e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—EGFR—asthma	5.6e-06	8.16e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS2—asthma	5.58e-06	8.13e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PDGFB—asthma	5.45e-06	7.94e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SERPINE1—asthma	5.35e-06	7.78e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PLA2G4A—asthma	5.31e-06	7.73e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTM1—asthma	5.31e-06	7.73e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALB—asthma	5.29e-06	7.7e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RHOA—asthma	5.16e-06	7.51e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOS3—asthma	5.1e-06	7.43e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NOS3—asthma	5.06e-06	7.36e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPP2CA—asthma	4.89e-06	7.12e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTEN—asthma	4.87e-06	7.09e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS2—asthma	4.86e-06	7.08e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—POMC—asthma	4.73e-06	6.88e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS2—asthma	4.63e-06	6.74e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL8—asthma	4.53e-06	6.59e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6R—asthma	4.37e-06	6.37e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2—asthma	4.33e-06	6.3e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALB—asthma	4.31e-06	6.28e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—asthma	4.3e-06	6.27e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NOS3—asthma	4.12e-06	6e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP9—asthma	4.09e-06	5.96e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SERPINE1—asthma	4.09e-06	5.96e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTEN—asthma	4.07e-06	5.93e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTEN—asthma	4.03e-06	5.87e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RHOA—asthma	3.95e-06	5.75e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS3—asthma	3.91e-06	5.69e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGS2—asthma	3.77e-06	5.49e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—POMC—asthma	3.75e-06	5.47e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VEGFA—asthma	3.68e-06	5.35e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—STAT3—asthma	3.64e-06	5.3e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CD4—asthma	3.6e-06	5.24e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALB—asthma	3.42e-06	4.98e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFB1—asthma	3.37e-06	4.91e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EGFR—asthma	3.31e-06	4.82e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTEN—asthma	3.29e-06	4.79e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NOS3—asthma	3.27e-06	4.77e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PTEN—asthma	3.12e-06	4.54e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—STAT3—asthma	2.79e-06	4.06e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PTEN—asthma	2.61e-06	3.8e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFB1—asthma	2.58e-06	3.76e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—asthma	2.54e-06	3.7e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EGFR—asthma	2.53e-06	3.69e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—asthma	1.95e-06	2.84e-05	CbGpPWpGaD
